Results 161 to 170 of about 710,167 (255)

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta‐analysis

open access: yesAddiction, Volume 121, Issue 11, Page 2897-2958, November 2026.
Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson   +13 more
wiley   +1 more source

Memantine, acetylcholinesterase inhibitors, and quality-of-care outcomes among patients with cognitive impairment: an emulated trial design. [PDF]

open access: yesAlzheimers Dement (N Y)
Ferguson EL   +8 more
europepmc   +1 more source

Opioid Modulation of Major Neurotransmitter Systems: Acute, Chronic, and Withdrawal Effects

open access: yesEuropean Journal of Neuroscience, Volume 64, Issue 9, November 2026.
Opioids are widely used but also frequently misused drugs that affect multiple neurotransmitter systems, including dopaminergic, glutamatergic, GABAergic, serotonergic, and cholinergic pathways. Opioid‐induced neuroadaptations depend on the duration of drug exposure, with distinct changes also emerging following drug discontinuation.
Daniela Novakova   +2 more
wiley   +1 more source

New Genomic Resources for an Invasive Mite Pest Expand the Known Diversity of Pesticide Resistance Mechanisms and Guide Development of KASP Diagnostic Markers

open access: yesEvolutionary Applications, Volume 19, Issue 11, November 2026.
ABSTRACT The redlegged earth mite, Halotydeus destructor, is an invasive pest of grain and pasture crops in Australia. Australian populations are increasingly developing resistance to broad‐spectrum pesticides. Here, we assembled a chromosome‐level genome for H. destructor, comprising nine chromosomes and totalling approximately 46 Mb.
Joshua A. Thia   +14 more
wiley   +1 more source

Real-world effectiveness of monoclonal antibody lecanemab versus acetylcholinesterase inhibitors in Alzheimer's disease: a target trial emulation. [PDF]

open access: yesAlzheimers Res Ther
Lee CY   +11 more
europepmc   +1 more source

Long-Term Effect of Acetylcholinesterase Inhibitors on Behavioral and Psychological Symptoms of Dementia. [PDF]

open access: yesInt J Geriatr Psychiatry
Zuliani G   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy